Good afternoon. I am Kim Sung-j in from the IR team at Hanwha Life. We're providing consecutive interpretation in Korean and English throughout the earnings call for the first quarter of 2024. The presentation materials are available on our IR website. Today, CFO [Im Seok-jung] will first give a report, followed by the Q&A session. Let me now hand over to our CFO.
[Non-English content]
Good afternoon. This is CFO [Im Seok-jung] . I would first like to thank you for joining our earnings call. Please note that today's presentation was prepared based on K-IFRS. Let me now begin the report on the earnings for the first quarter of 2024.
[ Non-English content]
Page four is on earnings highlights. In the first quarter of 2024, Hanwha Life was able to strengthen its medium to long-term earnings fundamentals by promoting continued growth of protection new business and improving sales efficiency through persistency enhancement. First, protection APE grew 133% year-over-year, sustaining a strong growth trend, and the new business CSM posted KRW 515.4 billion.
[ Non-English content]
In particular, the 13th month persistency ratio improved to around 93%, and the sales force exceeds 28,000 FPs, thereby maintaining the strongest channel competitiveness in the industry. While the separate net income posted KRW 175.5 billion, the consolidated net income posted KRW 368.3 billion, thanks to sound earnings contributions by key subsidiaries such as Hanwha General Insurance, Hanwha Life Financial Service, and the Vietnam subsidiary. Let me give you more details on the following slides.
[ Non-English content]
The new business APE grew 2.1% year-over-year, and the portion of protection policies expanded to 81%, contributing to quality improvement of the insurance portfolio.
[ Non-English content]
Protection APE was up 133% year-over-year to post KRW 900 billion , driven by new general protection products such as The H Health Insurance.
[ Non-English content]
Page six is on sales efficiency. The sales organization grew 14% year-over-year to 28,314 by hiring around 1,200 FPs per month on average.
[Non-English content]
The 13th month persistency ratio improved 7.3 percentage points quarter-over-quarter to 92.9%, thanks to contract persistency management efforts and system improvements, and the 25th month persistency ratio also increased by 2.6 percentage points. We will continue to reinforce efforts to manage persistency to further improve the value of in-force business under the new regimes.
[Non-English content]
Next is on CSM. We gained stable new business CSM of KRW 515.4 billion by making a shift to general protection products in response to the slowdown of the short-term premium paying whole life insurance market and secured visibility for achieving the annual guidance of KRW 2 trillion of new business CSM. The in-force CSM in the first quarter posted KRW 9.2 trillion .
[Non-English content]
Page eight, our separate net income reported KRW 175.5 billion , despite one-off factors such as the strengthening of the IBNR-related regulations.
[Non-English content]
Our consolidated net income hosted approximately KRW 370 billion , based on sound results of major subsidiaries, including KRW 125 billion from Hanwha General Insurance, KRW 14 billion from Hanwha Life Financial Services, and KRW 18 billion from the Vietnam subsidiary.
[Non-English content]
Page nine shows details on insurance and investment income. Despite one-off difference between the estimated and the actual due to stronger regulations on IBNR reserves, the insurance income posted KRW 91 billion , based on amortization profit generated from our in-force CSM. Excluding the impact of one-off IBNR issue, the insurance income is approximately KRW 176 billion , which is similar as last year.
[ Non-English content]
The investment income recorded around KRW 130 billion on the back of interest gains and disposal gains exceeding interest payments.
[ Non-English content]
Page 10 is on asset management. Our investment portfolio mainly consists of interest-bearing assets, and a portion of FVPL is reduced to 26% through strategic asset allocation.
[ Non-English content]
The investment yields posted 3.96%, up 60 basis points quarter-over-quarter, thanks to flexible asset management in consideration of market volatility.
[Non-English content]
As for our bond and loan portfolios, please refer to page 11 and page 12. Next, page 13 is on K-ICS and the duration gap.
[Non-English content]
Our K-ICS ratio saw a quarter-over-quarter drop to 174% due to the strengthening of liability discount rates, but we are committed to managing the year-end K-ICS ratio to be above 180% by expanding available capital through stable new business CSM inflow and reducing required capital.
[Non-English content]
The duration gap was reduced to 0.58 due to extended liability duration with changes to liability discount rates.
[Non-English content]
Finally, on page 14, after turning into black in 2023, Hanwha Life Financial Services posted KRW 13.8 billion of net income in the first quarter, thereby maintaining a profit trend.
[Non-English content]
The company is expected to achieve cumulative break-even point this year, and Hanwha Life Financial Services will maintain its number one position in the GA market by continuing to strengthen its channel competitiveness. Thank you for your attention.
[Non-English content] Now Q&A session will begin. Please press star one, star and one if you have any questions. Questions will be taken according to the order you have pressed the number star one. For cancellation, please press star two, that is star and two on your phone.
[Non-English content] The first question will be provided by Do Ha Kim from Hanwha Investment & Securities. Please go ahead with your question.
[Non-English content]
I'm Kim Do-ha from Hanwha Investment & Securities. Thank you for this opportunity. I would like to ask two questions. First of all, when it comes to the impact of changes to the IBNR regulations on page nine, you stated that there is an impact of KRW 88 billion that has resulted in the difference between the estimated and the actual. I believe this has to do with the application of the accident date that came into effect in March. I'd like to understand whether this has any impact on your honors contract as well, and its impact on not only your contracts, but also not only your profit and loss, but also your contracts in your portfolio. Secondly, when we take a look at the new business or new contract margin multiple, this has gone down much more than expected, especially for protection policies as well.
This may have to do with changes in your assumptions, but if you could provide us with more details on the reasons behind this drop in the multiple by breaking it into protection as well as general protection policies. I'd like to also understand what is your strategies to improve this multiple going forward.
[Non-English content]
I am Kim Jun-hee from the actuary team. Let me answer your first question. As you pointed out, there were some changes to the IBNR reserving. According to our initial business plan, it was supposed to be around KRW 85 billion. But when we closed the first quarter, it turned out to be KRW 88.3 billion.
[Non-English content]
This has to do with the recognition of damages and coverage that we have to provide as a result of the IBNR reserve increase. To be more specific, it was KRW 84 billion for BEL and KRW 3.7 billion for RA.
[Non-English content]
Moving on to your question on our new CSM margin multiple. Despite many changes to the assumptions as well as strengthening of regulations on discount rates that were applied last year, we were able to continue to increase our sales of general protection policies, including The H Health Insurance product. Therefore, we were able to increase the sales of protection policies, leading to a similar level of margin year-over-year.
[Non-English content]
However, when it comes to whole life products, there were changes to lapse ratio assumptions as well as a lower rate of discount rates. This had an impact on the sales of general protection. Overall, the percentage or the portion of general protection declined slightly. However, the margin or the profitability of general protection policies has maintained over 100% over APE.
[Non-English content]
While we anticipate some decline in the profitability going forward, we expect the sales volume of protection policies to continue to increase. Therefore, we believe that we will be able to achieve our initial or annual target of new business CSM for the year. Thank you.
[Non-English content]
I am Gu Chang-hee from the product development team. Let me provide additional comments on your question. As for The H Health Insurance, this was a very popular product in the first quarter of this year as part of the general protection policy category. To give you a comparison, in the first quarter of last year, the month initial premiums earned was KRW 4 billion. But this quarter in 2024, it went up to KRW 7.9 billion.
[Non-English content]
In the process of increasing the sales volume, there was a slight decline in the CSM multiple. However, we believe that this is a temporary phenomenon because going forward, The H Health Insurance will serve as a platform for general protection covers, and we will be able to add more covers on top of the basic coverage. Going forward from the second quarter, we will be able to add various benefits and coverages, including common illnesses and other diseases, which have a higher CSM margin. We believe that going forward, the CSM multiple for general protection policies will continue to improve.
[Non-English content]
[Non-English content]
[Non-English content]
For RA, it was KRW 3.7 billion.
[Non-English content]
[Non-English content]
[Non-English content] The following question will be presented by Hong Jae Lee from Hyundai Motor Securities. Please go ahead with your question.
[Non-English content]
I am Lee Hong-jae from Hyundai Motor Securities. Thank you for this opportunity. I would like to get more details on changes to the required capital side when it comes to your K-ICS ratio. We understand that there were some impacts from strengthening of the regulations regarding discount rates, but if you could give us some more details, we would appreciate that. For instance, other companies provided some data on net lapse risk and other factors. If you can share with us the interest rate risk amount for the end of the first quarter versus the previous quarter, we would like to learn more about that. Secondly, this is a similar question as to the previous question. There were some changes to discount rates as well as long-term forward rates. If you make a projection for 2027, how long do you think your liability duration will extend?
What is your estimation and projection given the current interest rates level? Thank you.
[Non-English content]
I am from the Risk Management Team , Park Ju-won. Let me answer your question. Compared to December, by the end of the first quarter of this year, the required capital is expected to increase by KRW 400 billion. For interest risk, the amount is KRW 200 billion. To be more specific, for net lapse risk, the amount is KRW 170 billion, and market risk amount is KRW 100 billion. In particular, related to the equity side, compared to the business plan, there is an increase of KRW 200 billion.
[Non-English content]
As for the operational risk amount, as of March 2024, the basic assumption risk will be incorporated. Given this change, we do not anticipate any increase in this risk category for March of 2024.
[Non-English content]
As for your question on the anticipated duration gap for 2027, given the continuous strengthening of the liability discount rate related regulations. Currently, as of the end of March, our duration gap is 0.58, which means that we have longer asset duration than the liability duration. However, when we assume that regulations will continue to strengthen by 2027, the duration gap will be - 0.7, which means that the liability duration will be longer than the asset duration by 0.7 years. Thank you.
[Non-English content]
[Non-English content]
So one quick follow-up question. What was the impact of changes to discount rates on your interest rate risk amount?
[Non-English content]
As of December 2023, the interest rate risk amount was KRW 1.2 trillion. But as of March 2024, it is estimated to be about KRW 1 trillion, which means that there is a decline of KRW 200 billion. And this is mainly because of the reduced duration gap compared to the end of December. Thank you.
[Non-English content]
[Non-English content] The following question will be presented by Young-joon Ahn from Hana Securities. Please go ahead with your question.
[Non-English content]
I am Ahn Young-joon from Hana Securities. I would like to ask two questions. You mentioned that your K-ICS ratio level that you would like to manage by the end of the year is 180%. I would like to know your strategies, how you are going to manage your K-ICS ratio, because while you have a good new business inflow of CSM, because of the adjustments of the increase, it is not likely to be very big. What is your overall K-ICS management strategy? Secondly, there was a news report about your investment in Nobu in Indonesia. Can you explain your overall overseas business strategies and when are you anticipating a positive impact of such investment on your profit going forward?
[Non-English content]
I am Park Ju-won from the Risk Management Team. Let me answer your question. First question on our K-ICS management strategy. In 2024, we will continue to drive the increase of new business CSM to increase available capital. Given our projections for the second quarter, third quarter, and all the way to the fourth quarter, we believe that new business CSM inflow will lead to an increase of K-ICS ratio by 10 percentage points. That is our conservative expectation. At the same time, given the continuous pricing of the liability discount rates, we will try to manage the duration gap. Currently, our asset duration is longer than the liability duration by more than 0.6 years. We will continue to manage our duration gap so that we can reduce the capital side volatility.
At the same time, we will utilize investment to be able to have enough capital buffer.
[Non-English content]
I am Yoon Jongguk from the Business Planning Administration. Let me address your second question on our investment in Nobu Bank. As you may know, this is a bank affiliate of Lippo Group, which is the sixth largest conglomerate in Indonesia, and the bank is ranked around 30th in the industry. Its asset size is KRW 2.3 trillion with the paid-in capital of KRW 300 billion, and its income is about KRW 12 billion, and the BIS ratio is 23.5%, which is much higher than the regulatory level. It has an overall sound business structure.
[Non-English content]
As for the type of management of Nobu Bank after we complete our investment, it is expected to be a joint management between Hanwha Life and Lippo Group. Nobu Bank will continue to focus on its core banking business model of utilizing the spread margin between interest for lending and interest for deposits. At the same time, we are going to identify and explore new growth engines by applying our advanced digital technology. You also asked a question about the financial impact or contribution from this investment. We expect that our investment is going to be completed in mid-2025, and our target equity stake is about 40%. When there are earnings generated from Nobu Bank, these will be recognized based on the equity method.
If they have net income of KRW 12 billion, then 40% of that will be recognized as part of the consolidated earnings. Thank you.
[Non-English content]
[Non-English content]
[Non-English content]
[Non-English content] The following question will be presented by Jun-Sup Jung from NH Investment & Securities. Please go ahead with your question.
[Non-English content]
I am Jung Jun-Sup from NH Investment & Securities. Thank you for this opportunity. I'd like to ask two questions. The first question is about resources that you can use for dividends in the first quarter. Given the new business CSM inflow, can you share with us some numbers on reserves for surrender, as well as resources available for dividend payout by the end of the year? I also like to understand whether there has been any progress at the regulators level in discussing improvement of regulations regarding surrender reserves. Secondly, it was reported in the media that the regulators may consider the validity or effectiveness of CSM amortization rates. I'd like to know whether there was any discussion on this matter, and what kinds of changes are you expecting from the regulators? Thank you.
[Non-English content]
I am Kim Dong-won from the finance team. Let me address your first question. There is an expectation of increasing surrender reserves in the first quarter of 2024. However, currently there is a task force team operating to improve this regulation, so we expect that there will be some resources available for dividend payout. When it comes to the current status of the task force team's operation, we have been working on this task force team since March, together with lifers and non-lifers , as well as the association. The overall direction is to reduce surrender related reserves in order to increase the base for corporate tax revenue.
[Non-English content]
Please understand that we are not able to share with you any specific amount as per how much we can attribute to dividend payout at this moment, but we believe that we will be able to secure enough funds for dividends by working through the task force team to reduce surrender related reserves going forward. Thank you.
[Non-English content]
I am Kim Jun-hee from the actuary team. Let me give you more details on the progress of the task force team as well as our own surrender related reserves.
[Non-English content]
At the task force team, three options were considered. First of all, the first option was to relax the criteria for surrender reserves. Secondly, there was a recognition that initial reserves for surrender payment for new business was too large. There were discussions on improving on this aspect. Third, there was a discussion of allocating a portion of the reserves for additional provisioning.
[Non-English content]
Among these three options, the third option was preferred according to some reports. However, this is not finalized yet, so we need to go through further discussions before finalizing an option.
[Non-English content]
Moving on to our own reserve structure for Hanwha Life. When we look at inforce policies before 2023 and new business or new policies in 2023, the changes are quite similar at their level. There may be some impact of increase in new business sales, but overall, the changes are similar.
[Non-English content]
Given the contract volume in the first quarter and given the changes expected through the reduction of surrender reserves at the beginning of the contract period, we expect an increase of about KRW 1 trillion. Thank you.
[Non-English content]
I now like to address your second question on the guidance by FSS.
[Non-English content]
There are three main topics that are under discussion at the FSS, but these are not necessarily called guidelines, but these are activities that are done by the FSS to understand the current situation in the industry at the working level.
[Non-English content]
The first topic is related to the accounting of future changes to announced rates as for floating rate policies. So whether they should be accounted based on the net profit and loss or as part of the other comprehensive income.
[Non-English content]
Secondly, there are discussions on how to recognize other comprehensive income that has been accrued when contracts expire. The third topic is about CSM amortization related changes. However, nothing has been completely finalized because these are discussions at the working level, and this is basically about getting input from the industry regarding methodologies. Thank you.
[Non-English content]
[Non-English content]
[Non-English content]
[Non-English content] The following question will be presented by Lee Byung-gun from DB Financial Investment. Please go ahead with your question.
[Non-English content]
[Non-English content]
Okay. I am Lee Byung-gun from DB Financial Investment. I would like to ask two questions. My first question has to do with getting more details on the impact of new business profitability adjustment on your whole life category. As far as we know, the single or short-term premium paying whole life, there was some competitions in the first quarter, especially in January. This may also have to do with a worsening of the profitability for your whole life products. As you mentioned already, there were changes to discount rates, there were changes to lapse rates. These may have an impact on your whole life profitability. So what was the overall impact on your whole life performance? If you can carve out the single premium payment or a short-term premium paying whole life as well, then this would be really appreciated.
Because there were some changes, as I mentioned, to discount rates and lapse rates, and these may have an impact on your profitability, not only this year or the first quarter, but also last year. So I would like to understand the mechanism as to what happened to your whole life product performance. The second question has to do with the increase in new business CSM versus in-force CSM. You provided us with the in-force CSM movement, and there may be several reasons why, but it seems that in the first quarter, the new business CSM did not increase substantially. When we exclude unwind, new business CSM is KRW 516 billion , but there was so much adjustment applied to that. So practically speaking, CSM didn't increase that much. So I'd like to understand the reasons why there were such big adjustments, especially when it comes to your assumption adjustments.
[Non-English content]
I am Kim Jun-hee from Actuary team. Let me answer your question on the profitability of whole life category. As you mentioned, there were some changes to the persistency ratio and also surrender rates and so on. So whole life portfolio performance declined.
[Non-English content]
In particular, 30% decline over APE and 340% over month initial. This is mainly because short-term premium paying whole life policies depend on interest spread or difference between the interest rates. However, because of the decline in the persistency ratio, the whole life, especially a short-term premium paying whole life policies lost their profitability.
[Non-English content]
In recognition of this issue, we have been actively restructuring our portfolio and changing our attention from whole life to general protection policies starting from the first quarter of this year. So we believe that we will be able to meet and secure enough CSM inflow for the entire year.
[Non-English content]
Moving on to your second question on our CSM movement.
[Non-English content]
In the first quarter, the outstanding CSM stands at KRW 9.24 trillion, there was an increase of KRW 510 billion, thanks to new business CSM, there was a drop of KRW 135.8 billion because of unwinding, the CSM amortization rate was 9.3%.
[Non-English content]
When it comes to the details regarding the experiential adjustments applied to the CSM, starting from the first quarter of this year, there were changes to discount rates, especially for variable policy blocks. This led to some changes in our actuarial assumptions, these are rather one-off, the amount is KRW 200 billion.
[Non-English content]
Usually, general protection policies are recognized and treated as part of OCI, but for variable policies, we use VFA methodology.
[Non-English content]
The remaining changes are rather ordinary on a quarter-over-quarter basis. Because of the difference between the estimated and the actual, because of the changes in the nature of contracts in our portfolio, there was a negative impact of KRW 150 billion.
[Non-English content]
Overall, we believe that our new business CSM inflow was sufficient to cover for any concerns related to a downward interest rate movement. As we mentioned during discussions on K-ICS, the duration gap management will continue to be able to buffer or protect us from any regulatory changes.
[Non-English content]
Thank you.
[Non-English content]
[Non-English content]
[Non-English content]
[Non-English content]
I would like to make one suggestion and one follow-up question. As for my suggestion, I would appreciate it if you could carve out the portion or movements related to a variable fee portion. You mentioned about VFA methodology, and this doesn't necessarily mean any adjustments to CSM. If you have just to look at the general model, the results would look quite different. So if you can carve that out as part of your assumption changes, this will help us better understand your performance. Moving on to my follow-up question. When I asked a question about your whole life margin or profitability performance, it has actually gone down by threefolds, and this, I believe, is mainly due to the surrender rate related issue.
My question is, I know that you will continue to sell whole life products going forward, because that is one of the major product categories in your portfolio. So what kind of level of profitability should we anticipate? Do you think that the current margin level will continue for some time? Or what will be the appropriate level of profitability of whole life products?
[Non-English content]
I'm Gu Chang-hee from product development. Let me answer your questions regarding whole life. As you mentioned, the CSM multiple for whole life is extremely low right now, and we understand that there is a concentration in our whole life portfolio towards single or short-term premium paying whole life policies through product development and sales. We're going to address this.
[Non-English content]
Starting from the second quarter, we are going to make a shift from short-term premium paying policies to selling more of a medium and long-term premium paying policies, and we will continue to launch new protection covers that can be placed on top of whole life policies. Indeed, we are making a shift to more high CSM margin policies in our portfolio. For instance, in April, we've added some protection or health-related benefits on top of the whole life policies, and this is a shift of strategy that we're implementing, and we are producing some tangible results. So going forward, we will continue to diversify our whole life portfolio.
[Non-English content]
I am Kim Jun-hee from the actuary team. Let me comment on your follow-up question. We are well aware of the point that you made about variable product and the changes or movements of the CSM. However, I would like to explain that the reason why we did not provide a breakdown is because the impact of cancellation or surrender under VFA, the impact is very minimal on our net income or net profit and loss, and the impact is around KRW 10 billion.
[Non-English content]
[Non-English content]
[Non-English content]
[Non-English content] The following question will be presented by Trung from CreditSights. Please go ahead with your question.
Yes. Thank you. By the way, can you hear me?
Yes.
All right, great. Yes, I have a couple questions. The first part is with regard to the investment result. I note that the investment profit has declined quite a lot on a year-on-year basis. Could the management provide some comment on this decline? And whether an analyst should be worried about this performance. The second question is, in anticipation of any rate cut by the central bank in, let us say, the second half of this year, what would the management think of any potential impact on the product development or investment outcome as a result of that rate cut and any response in the future that we should anticipate? Thank you.
[Non-English content]
[Non-English content]
I'm Shin Sang-wook from the investment strategy team. Let me answer your first question on our investment performance. In 2023, the first quarter, the investment income was KRW 433 billion. Compared to that, in the first quarter of this year, the investment income was KRW 130 billion. You may think that there was a big decline. However, back in 2023, there were many trading of replacing short-term bonds with long-term bonds, as well as accounts reclassification, and that is why there was a large amount of disposal gains that we recognized for the first quarter last year. On a year-over-year basis, you may think that the investment income declined dramatically. However, this is mainly because of the base effect from the first quarter of last year with disposal gains.
[Non-English content]
Moving on to your second question on anticipated rate cuts, both in Korea and overseas, the market is expecting about one or two rounds of rate cuts within this year, and this one or two rounds of rate cuts have already been reflected in the market. Given the fact that we have longer asset duration than the liability duration, and given the structure of our investment portfolio, if there are some moderate rate cuts going forward in the second half, this may have actually a positive impact on our investment performance. We do not anticipate any major negative impact on our investment portfolio with respect to rate cuts.
Okay. Was it enough for your question?
Yes. Thanks for the clarifications. Just one follow-up question on the investment performance. With regard to the variable profit and the retirement profit, I also note that there is also a decline. Could you please explain a bit more on this movement?
[Non-English content]
Once again, I am Shin Sang-wook from the investment strategy team. Let me address your follow-up question. As for the variable side performance, it is nothing really to do with the operation itself, but with respect to the hedging. As was explained by the head of the actuarial team, we are utilizing VFA model for variable accounts. When you look at our P&L statement, you can see that the P&L volatility has actually been reduced, and we believe that this level will be maintained throughout the year.
[Non-English content]
As for the retirement account, just like the general account, there was a reclassification activity that went on in the first quarter of last year, and this resulted in a large amount of disposal gains in the process of replacing some of the assets in the portfolio. Because of the base effect, you may think that there is a big difference.
However, on a year-over-year basis, on an annual basis, you can see that there is a reduced volatility. Thank you.
Do you have any other questions?
Nope. That is all. Thank you so much.
Thank you. [Non-English content]
[Non-English content] The following question will be presented by Do Ha Kim from Hanwha Investment & Securities. Please go ahead with your question.
[Non-English content]
I am Kim Do-ha from Hanwha Investment & Securities. I would like to ask two follow-up questions. First of all, when there was a question about the expected duration extension by 2027, given strengthened regulations, you just answered in terms of the duration gap. I would like to understand to what extent your liability duration is going to increase by 2027. The second question has to do with the decline of your K-ICS ratio on a quarter-over-quarter basis by 10 basis points. If you could give us a breakdown of which factors contributed to a 10 percentage point decline, and to what degree, we will appreciate that.
[Non-English content]
I am Park Ju-won from the risk management team. Regarding the duration gap related to the K-ICS ratio. As for the asset side, the asset side duration is based on the assumption that our asset management activities will be pretty much the same as the previous years. We did not take into account any possibility of increasing certain categories of funds in our portfolio.
[Non-English content]
As for your second question, the drivers behind the 10 percentage point decline in the K-ICS ratio on a quarter-over-quarter basis. On a quarter-over-quarter basis, there was a negative impact of 14 percentage points decline on the K-ICS ratio because of the interest rate increases as well as the strengthening of the discount rates. There was a positive contribution coming from the new business CSM of KRW 500 billion, and this boosted the K-ICS ratio by 4 percentage points.
[Non-English content]
[Non-English content]
[Non-English content]
[Non-English content] The following question will be presented by Myung Wook Kim from JP Morgan. Please go ahead with your question.
[Non-English content]
[Non-English content]
I am Myung Wook Kim from JP Morgan. Thank you for the opportunity. First of all, your earnings for the first quarter are not as big as others, so I'd like to understand the overall guidance on your dividend policy because some other companies provided guidance on their dividend policy for the year. Given your capital level and given a lot of factors taking place, what will be the reasonable anticipation of the dividend level that we can expect from Hanwha Life? We would appreciate some guidance. Secondly, you mentioned already about the potential interest rate cuts going forward in the year. If the interest rate is down by, let's say, by 100 basis points, what will be the impact on your K-ICS ratio? What will be your capital contingency plan that you have internally?
And third, your CSM balance does not seem to be moving substantially. I wonder if you have calculated EV of the new policies that you are selling these days. I would like to know whether the policies you are selling will bring about a surplus or profit for your business because the CSM margin seems pretty okay, but what will be the future profitability of the policies that you are selling right now?
[Non-English content]
I am Kim Dong-won from the finance team. Because we just passed the first quarter, it may be too early to discuss our full year earnings. However, we believe that we will be able to produce tangible earnings results for our investors and shareholders. As for the dividend payout ratio or the policy, we are going to follow the guidance of the government in promoting the benefits for the shareholders and shareholder returns. We will do our best to expand funds available for dividend payouts to our shareholders. Thank you.
[Non-English content]
I am Park Ju-won from the risk management team. As for your second question on the impact of interest rate cut by 100 basis points on our K-ICS ratio, to give you a reference for the government treasury tenure is going down by 10 basis points. This will have a negative impact on our K-ICS ratio by 0.5 percentage points. This is on a 10 basis points movement. If you apply 100 basis points, you cannot just multiply it by five, but rather the impact is expected to be a little larger than 5%, somewhere between 5%-8%.
[Non-English content]
As for the contingency plan, we do not consider a 100 basis points cut as a contingency situation because what we mean by contingency internally will be much more than that and a little lower than 2 percentage points change in the interest rate. Given such a scenario, we will continue to maintain our bond duration to be longer than the liability duration. We will consider options such as co-reinsurance to be prepared for the period where interest rates continue to get lower. Thank you.
[Non-English content]
I'm Kim Jun-hee from the actuary team. As for the EV valuation or EV perspective of estimating or calculating profitability, this is something that requires internal discussions, whether we're going to disclose this or not. To give you some reference, since last year, we have been calculating and announcing profitability of our business under the new regimes.
[Non-English content]
There are two main points that we are going to consider internally. First of all, there are some issues or controversies over the methodology of using EV as an approach. Secondly, in calculating EV with the capital charge, the level of capital charge has not been agreed on a broader basis. These are the two points that will need to be discussed internally.
[Non-English content]
We will see when and how such a consensus on these two aspects will be reached, and then we will see what we can do at that point. Thank you.
[Non-English content]
[Non-English content]
[Non-English content]
With no further questions, I would like to invite back our CFO for his closing remarks before we end today's conference call.
[Non-English content]
Since the introduction of IFRS 17, Hanwha Life has been pursuing profitability-oriented management strategies focused on protection-centered insurance portfolio and enhancing sales efficiency. We have been demonstrating strong growth trends through continuous organization expansion.
[Non-English content]
While unfavorable business circumstances continue, such as sharp interest rate movements and high inflation, we are committed to making company-wide efforts to reinforce our core competitiveness in terms of insurance operation and asset management so that we can share the benefits of enhanced corporate value with our investors.
[Non-English content]
In 2023, we recorded pre-tax income of KRW 753.4 billion and a net income of KRW 616.3 billion , and our K-ICS ratio was 183.8%. In 2024, we are implementing optimal strategies to exceed the profitability and the soundness results that we achieved in 2023. We would like to ask for your continued support and interest, and we will make sure that all these earnings and results will be actively reflected in our shareholder return policy. I hope that today's earnings call was a valuable opportunity for you to better understand our business. Thank you for your attention.